These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 38355808)
1. Heterogeneity and tumoral origin of medulloblastoma in the single-cell era. Sheng H; Li H; Zeng H; Zhang B; Lu Y; Liu X; Xu Z; Zhang J; Zhang L Oncogene; 2024 Mar; 43(12):839-850. PubMed ID: 38355808 [TBL] [Abstract][Full Text] [Related]
3. Treatment results of adults and children with medulloblastoma NCI, Cairo University experience. Khalil EM J Egypt Natl Canc Inst; 2008 Jun; 20(2):175-86. PubMed ID: 20029474 [TBL] [Abstract][Full Text] [Related]
4. SEOM clinical guideline for management of adult medulloblastoma (2020). Luque R; Benavides M; Del Barco S; Egaña L; García-Gómez J; Martínez-García M; Pérez-Segura P; Pineda E; Sepúlveda JM; Vieito M Clin Transl Oncol; 2021 May; 23(5):940-947. PubMed ID: 33792841 [TBL] [Abstract][Full Text] [Related]
5. DNA content and other prognostic features in childhood medulloblastoma. Proposal of a scoring system. Schofield DE; Yunis EJ; Geyer JR; Albright AL; Berger MS; Taylor SR Cancer; 1992 Mar; 69(5):1307-14. PubMed ID: 1739930 [TBL] [Abstract][Full Text] [Related]
6. Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification. Polkinghorn WR; Tarbell NJ Nat Clin Pract Oncol; 2007 May; 4(5):295-304. PubMed ID: 17464337 [TBL] [Abstract][Full Text] [Related]
8. Pediatric medulloblastoma in the molecular era: what are the surgical implications? Kameda-Smith MM Cancer Metastasis Rev; 2020 Mar; 39(1):235-243. PubMed ID: 32095940 [TBL] [Abstract][Full Text] [Related]
9. Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial. Robinson GW; Rudneva VA; Buchhalter I; Billups CA; Waszak SM; Smith KS; Bowers DC; Bendel A; Fisher PG; Partap S; Crawford JR; Hassall T; Indelicato DJ; Boop F; Klimo P; Sabin ND; Patay Z; Merchant TE; Stewart CF; Orr BA; Korbel JO; Jones DTW; Sharma T; Lichter P; Kool M; Korshunov A; Pfister SM; Gilbertson RJ; Sanders RP; Onar-Thomas A; Ellison DW; Gajjar A; Northcott PA Lancet Oncol; 2018 Jun; 19(6):768-784. PubMed ID: 29778738 [TBL] [Abstract][Full Text] [Related]
10. Shedding light on adult medulloblastoma: current management and opportunities for advances. Brandes AA; Franceschi E Am Soc Clin Oncol Educ Book; 2014; ():e82-7. PubMed ID: 24857151 [TBL] [Abstract][Full Text] [Related]
11. Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept. Rieken S; Gaiser T; Mohr A; Welzel T; Witt O; Kulozik AE; Wick W; Debus J; Combs SE BMC Cancer; 2010 Aug; 10():450. PubMed ID: 20731859 [TBL] [Abstract][Full Text] [Related]
12. Medulloblastoma: From Molecular Subgroups to Molecular Targeted Therapies. Wang J; Garancher A; Ramaswamy V; Wechsler-Reya RJ Annu Rev Neurosci; 2018 Jul; 41():207-232. PubMed ID: 29641939 [TBL] [Abstract][Full Text] [Related]
13. Very late relapse of medulloblastoma. Cieślak E; Kepka L; Fijuth J; Marchel A; Kroh H Folia Neuropathol; 2004; 42(1):49-53. PubMed ID: 15119746 [TBL] [Abstract][Full Text] [Related]
14. High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy. Ridola V; Grill J; Doz F; Gentet JC; Frappaz D; Raquin MA; Habrand JL; Sainte-Rose C; Valteau-Couanet D; Kalifa C Cancer; 2007 Jul; 110(1):156-63. PubMed ID: 17541945 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological features of medulloblastoma: an overview with an emphasis on molecular biology. de Haas TG; Kool M Clin Neuropathol; 2007; 26(3):93-110. PubMed ID: 19157001 [TBL] [Abstract][Full Text] [Related]
16. Isolated Bone Recurrence of Medulloblastoma With MYCN Amplification and TP53 Loss: A Case Report. Takahashi Y; Kudo K; Ogawa K; Sato T; Kamio T; Sasaki S; Kobayashi A; Ito T; Yamamoto T; Asano K; Ohkuma H; Kurose A; Ito E; Terui K J Pediatr Hematol Oncol; 2022 Mar; 44(2):e593-e596. PubMed ID: 34133388 [TBL] [Abstract][Full Text] [Related]
17. Medulloblastoma in the age of molecular subgroups: a review. Juraschka K; Taylor MD J Neurosurg Pediatr; 2019 Oct; 24(4):353-363. PubMed ID: 31574483 [TBL] [Abstract][Full Text] [Related]
18. New Approaches in Targeted Therapy for Medulloblastoma in Children. Maier H; Dalianis T; Kostopoulou ON Anticancer Res; 2021 Apr; 41(4):1715-1726. PubMed ID: 33813375 [TBL] [Abstract][Full Text] [Related]